Type VII collagen is required for Ras-driven human epidermal tumorigenesis

Area of Science:

• Dermatology
• Oncology
• Molecular Biology

Background:

• Recessive dystrophic epidermolysis bullosa (RDEB) is a severe blistering skin disease caused by defects in type VII collagen.
• RDEB patients exhibit an increased susceptibility to developing epidermal cancers, particularly squamous cell carcinoma.

Purpose of the Study:

• To investigate the role of type VII collagen in Ras-driven tumorigenesis within RDEB keratinocytes.
• To determine if specific fragments of type VII collagen influence tumor formation and progression.

Main Methods:

• Examined Ras-driven tumorigenesis in collagen VII-deficient RDEB keratinocytes in a mouse model.
• Assessed the impact of expressing a specific collagen VII fragment (NC1) on tumor formation.
• Investigated the role of fibronectin-like sequences within NC1 (FNC1) in tumor cell invasion and laminin 5 interactions.

Main Results:

• Keratinocytes lacking collagen VII failed to form tumors in mice.
• Retention of the NC1 fragment of collagen VII restored tumorigenicity to collagen VII-null epidermis.
• Forced expression of NC1 promoted tumor formation in a non-cell-autonomous manner.
• Fibronectin-like sequences (FNC1) within NC1 were essential for tumor cell invasion and overall tumorigenesis, acting in a laminin 5-dependent pathway.

Conclusions:

• Tumor-stroma interactions mediated by type VII collagen play a significant role in promoting neoplasia.
• The retention of NC1 sequences in some RDEB patients may contribute to their heightened risk of squamous cell carcinoma.
• Targeting collagen VII fragments could offer therapeutic strategies for RDEB-associated cancers.